{"schema_version":"secwatch.filing_event.v1","accession":"0001654954-26-002304","form_type":"8-K","ticker":"ZOMDF","cik":"0001684144","company_name":"Zomedica Corp.","filed_at":"2026-03-16T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.886801+00:00","generated_at":"2026-05-15T11:49:05.916631+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Zomedica reports record Q4 revenue $10.5M, full-year revenue $32.0M (+17% YoY)","bullets":["Q4 revenue $10.5M (+33% YoY); full year $32.0M (+17%). Record 20th straight YoY increase.","Gross margin 68% for year; Q4 69% best quarter. Adjusted EBITDA loss improved to $17.1M from $20.2M.","Cash burn reduced to $18.1M for year, $1.1M in Q4; cash/securities $53.3M.","Consumable revenue grew 16% to $20.7M; Development Services segment contributed $3.1M.","Net loss $81.9M includes $55.8M non-cash impairment; operating expenses ex-impairment down 7%."],"urls":{"canonical":"https://secwatch.observer/filing/0001654954-26-002304","json":"https://secwatch.observer/filing/0001654954-26-002304.json","markdown":"https://secwatch.observer/filing/0001654954-26-002304.md","text":"https://secwatch.observer/filing/0001654954-26-002304.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1684144/000165495426002304/0001654954-26-002304-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1684144/000165495426002304/zom_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T11:49:05.916631+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}